Edition:
India

Koninklijke Philips NV (PHG.AS)

PHG.AS on Amsterdam Stock Exchange

38.96EUR
9:05pm IST
Change (% chg)

€-0.04 (-0.10%)
Prev Close
€38.99
Open
€38.99
Day's High
€39.28
Day's Low
€38.61
Volume
1,865,227
Avg. Vol
2,577,389
52-wk High
€39.83
52-wk Low
€29.25

Latest Key Developments (Source: Significant Developments)

Philips And Integron Collaborate On Integrated Digital Health Solutions
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND INTEGRON COLLABORATE ON INTEGRATED DIGITAL HEALTH SOLUTIONS.  Full Article

Gibson Brands Reaches Global Settlement And Files Amended Plan Of Reorganization
Friday, 7 Sep 2018 

Sept 6 (Reuters) - Gibson Brands Inc [RIC:RIC:GIBSN.UL]::GIBSON BRANDS REACHES GLOBAL SETTLEMENT AND FILES AMENDED PLAN OF REORGANIZATION.GIBSON BRANDS INC - AMENDED PLAN TO PROVIDE SETTLEMENT OF THREATENED LITIGATION AGAINST GSO, SUPPORTING PRINCIPALS, AND OTHERS.GIBSON BRANDS - EFFECTIVE SEPT. 6, BRIAN FOX OF ALVAREZ AND MARSAL TO OVERSEE CO'S DAILY OPERATIONS IN ROLE AS CRO UNTIL CEO SUCCESSOR APPOINTED.GIBSON BRANDS - WHEN AMENDED PLAN IS CONFIRMED AND GOES EFFECTIVE, HENRY JUSZKIEWICZ WILL STEP DOWN FROM HIS POSITION AS CEO.GIBSON BRANDS - WILL BE SENDING NEW BALLOTS TO, EXTEND VOTING DEADLINE FOR HOLDERS OF CLAIMS IN CLASSES 6 AND 8 ONLY.GIBSON BRANDS INC - AMENDED PLAN TO PROVIDE SUSPENSION OF DISCOVERY AND LITIGATION OVER PLAN AND CERTAIN ASSERTED CLAIMS.GIBSON BRANDS - PLAN HAS BEEN AMENDED TO PROVIDE AGREED ALLOWANCE AND PLAN TREATMENT FOR GSO'S AND PHILIPS' CLAIMS AGAINST CO.GIBSON BRANDS INC - COMMITMENTS BY GSO CAPITAL PARTNERS LP , KONINKLIJKE PHILIPS N.V. , AND COMMITTEE TO SUPPORT CONFIRMATION OF AMENDED PLAN.GIBSON BRANDS INC - EXPECT GIBSON CAN EMERGE FROM CHAPTER 11 DURING Q4 OF THIS YEAR.  Full Article

Signify Starts 230 Million Euros Share Repurchase Program
Monday, 30 Jul 2018 

July 30 (Reuters) - SIGNIFY NV ::REG-SIGNIFY STARTS EUR 230 MILLION SHARE REPURCHASE PROGRAM.PROGRAM IS IN LINE WITH SIGNIFY'S ANNOUNCEMENT OF JULY 27, 2018 AND WILL START ON JULY 30, 2018..REPURCHASE PROGRAM REPRESENTS A TOTAL OF APPROXIMATELY 9.9 MILLION SHARES OR 7.2% OF COMPANY'S ISSUED SHARE CAPITAL.  Full Article

Koninklijke Philips Q2 Sales 4.3 Billion Euros
Monday, 23 Jul 2018 

July 23 (Reuters) - KONINKLIJKE PHILIPS NV ::Q2 RESULTS.SALES IN THE QUARTER WERE EUR 4.3 BILLION, WITH COMPARABLE SALES GROWTH OF 4%.WE REITERATE OUR TARGETS FOR THE 2017–2020 PERIOD.Q2 INCOME FROM OPERATIONS (EBIT) INCREASED TO EUR 298 MILLION, COMPARED TO EUR 252 MILLION IN Q2 2017.OPERATING CASH FLOW TOTALED EUR 130 MILLION, COMPARED TO EUR 73 MILLION IN Q2 2017.NET INCOME FROM CONTINUING OPERATIONS WAS EUR 186 MILLION, COMPARED TO EUR 161 MILLION IN Q2 2017.Q2 ADJUSTED EBITA MARGIN IMPROVED BY 100 BASIS POINTS TO 11.2% OF SALES, COMPARED TO 10.2% OF SALES IN Q2 2017.WE SIGNED SEVEN LONG-TERM STRATEGIC PARTNERSHIP AGREEMENTS IN THE QUARTER..PHILIPS IS ON TRACK TO DELIVER ANNUAL SAVINGS OF EUR 400 MILLION IN 2018..Q2 REUTERS POLL: SALES EUR 4.35 BLN; EBITA EUR 405 MLN; NET INCOME EUR 218 MLN.  Full Article

Philips Signs Two Long-Term Strategic Partnership Agreements In Germany
Thursday, 12 Jul 2018 

July 12 (Reuters) - KONINKLIJKE PHILIPS NV ::KLINIKEN DER STADT KÖLN AND PHILIPS SIGN 15-YEAR PARTNERSHIP CONTRACT.KLINIKEN DER STADT KÖLN CONTRACT VALUED AT APPROX EUR 90 MILLION.SIGNS 8-YEAR STRATEGIC INNOVATION PARTNERSHIP AGREEMENT WITH STÄDTISCHE KLINIKUM MÜNCHEN.STÄDTISCHE KLINIKUM MÜNCHEN CONTRACT VALUED AT APPROX EUR 50 MILLION.AS PART OF BOTH AGREEMENTS, PHILIPS WILL INSTALL IQON SPECTRAL CT SOLUTIONS IN BOTH HOSPITALS.  Full Article

Koninklijke Philips Provides Update On European Commission Investigation
Friday, 6 Jul 2018 

July 6 (Reuters) - Koninklijke Philips NV ::PHILIPS PROVIDES UPDATE ON EUROPEAN COMMISSION INVESTIGATION.UPDATE ON EUROPEAN COMMISSION'S INVESTIGATION INTO ONLINE PRICE SETTING FOR CONSUMER ELECTRONICS PRODUCTS AND SMALL DOMESTIC APPLIANCES IN PERIOD NOVEMBER 2011 TO NOVEMBER 2013..WILL RECOGNIZE A PROVISION OF EUR 30 MILLION, WHICH WILL BE REPORTED IN THE COMPANY’S 2018 SECOND QUARTER RESULTS.PHILIPS WILL RECOGNIZE A PROVISION OF EUR 30 MILLION, WHICH WILL BE REPORTED IN COMPANY'S 2018 Q2 RESULTS.APPROX. EUR 18 MILLION OF PROVISION WILL IMPACT EBITA OF PERSONAL HEALTH SEGMENT..THIS AMOUNT WILL NOT IMPACT ADJUSTED EBITA OF PERSONAL HEALTH SEGMENT..REMAINING APPROX. EUR 12 MILLION OF PROVISION WILL BE REPORTED IN DISCONTINUED OPERATIONS.  Full Article

Koninklijke Philips Powers First Tele-Intensive Care EICU Program In Japan
Tuesday, 3 Jul 2018 

July 3 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS POWERS FIRST TELE-INTENSIVE CARE EICU PROGRAM IN JAPAN.  Full Article

Philips And Jackson Health System Sign 11-Year Agreement For Enterprise Monitoring As Service
Wednesday, 27 Jun 2018 

June 27 (Reuters) - KONINKLIJKE PHILIPS NV ::PHILIPS AND JACKSON HEALTH SYSTEM SIGN GROUNDBREAKING 11-YEAR AGREEMENT FOR ENTERPRISE MONITORING AS A SERVICE.  Full Article

Philips Signs Agreement With Gov'ts Of Ethiopia And Netherlands To Build Cardiac Care Center in Ethiopia
Thursday, 24 May 2018 

May 24 (Reuters) - KONINKLIJKE PHILIPS NV ::SIGNS WITH GOVERNMENT OF ETHIOPIA AND NETHERLANDS 7-YEAR AGREEMENT TO BUILD ETHIOPIA’S SPECIALIZED CARDIAC CARE CENTER.AGREEMENT VALUED AT APPROXIMATELY 40 MILLION EURO.WILL BE RESPONSIBLE FOR FULL TURNKEY DESIGN, CONSTRUCTION, EQUIPPING AND COMMISSIONING OF HOSPITAL LOCATION.WILL BE RESPONSIBLE FOR STAFF EDUCATION AND EQUIPMENT MAINTENANCE FOR 5 YEARS AFTER COMPLETION.  Full Article

Philips To Enter Global Brand License Agreement With TPV Technology
Wednesday, 23 May 2018 

May 23 (Reuters) - KONINKLIJKE PHILIPS NV ::HAS SIGNED A BINDING LETTER OF INTENT WITH TPV TECHNOLOGY LIMITED.WITH TPV TO ENTER GLOBAL BRAND LICENSE AGREEMENT FOR AUDIO AND VIDEO PRODUCTS AND ACCESSORIES.PHILIPS WILL GRANT TPV EXCLUSIVE LICENSE AGREEMENT TO USE PHILIPS BRAND IN AV PRODUCTS, ACCESSORIES WORLDWIDE.  Full Article

UPDATE 2-Signify shares rally as share buybacks outweigh cut in outlook

* Signify shares rise 8 pct after sharp drop in first half of 2018 (Adds share price and analyst reaction, more detail on Q2 results, CEO quotes)